2020
DOI: 10.1016/j.transproceed.2020.03.046
|View full text |Cite
|
Sign up to set email alerts
|

Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Particular Consideration for Idiopathic Pulmonary Arterial Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 10 publications
0
10
1
Order By: Relevance
“…This can be attributed to both a younger absolute age at time of transplantation and nature of the underlying disease leading to improved survival with each subsequent year of survival post-transplant. Cystic fibrosis has previously been shown to have the highest unconditional survival at 1 year 25 but did not extrapolate to the increasing conditional survival with each subsequent year of survival as shown in this study.…”
Section: Commentcontrasting
confidence: 90%
“…This can be attributed to both a younger absolute age at time of transplantation and nature of the underlying disease leading to improved survival with each subsequent year of survival post-transplant. Cystic fibrosis has previously been shown to have the highest unconditional survival at 1 year 25 but did not extrapolate to the increasing conditional survival with each subsequent year of survival as shown in this study.…”
Section: Commentcontrasting
confidence: 90%
“…Although there have been no studies comparing single and double lung transplant in CPFE patients specifically, studies have shown no difference in outcomes for single versus double lung transplant in any patient diagnosed with ILD. 10,12 In this case, the successful SLT allowed for complete resection of the patient's cancer with good postoperative quality of life. The incidence of lung cancer development in post-lung transplant patients is reported to be as high as 2.4%.…”
Section: Discussionmentioning
confidence: 85%
“…Additionally, potential right ventricular dysfunction and high pulmonary blood flow after a single LTx can increase the incidence and severity of PGD [ 48 ]. In a single-center experience, the 5-year survival rate of recipients with PAH who underwent bilateral LTx and single LTx reached 84% and 51%, respectively, which further clarified the survival benefit of bilateral LTx [ 49 ]. Moreover, a severe shortage of heart–lung blocks has been a significant obstacle in the field of HLTx, and henceforth HLTx will be reserved for patients with other uncorrectable heart conditions, including Eisenmenger syndrome complicating complex congenital heart disease (CHD), failed CHD repair, uncorrectable CHD, and severe left ventricular failure [ 50 ].…”
Section: Treatment Algorithms For Patients With Pahmentioning
confidence: 99%